Pages that link to "Q36862351"
Jump to navigation
Jump to search
The following pages link to The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release (Q36862351):
Displaying 50 items.
- MDMA for the treatment of mood disorder: all talk no substance? (Q21558551) (← links)
- Plasma membrane monoamine transporters: structure, regulation and function (Q22251021) (← links)
- Comparative study of fluoxetine, sibutramine, sertraline, and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry (Q23917497) (← links)
- Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2 (Q24298107) (← links)
- Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter (Q24314400) (← links)
- A human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPs (Q24321541) (← links)
- Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy (Q24612266) (← links)
- Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys (Q24629918) (← links)
- A current view of serotonin transporters (Q26740309) (← links)
- Insights to ligand binding to the monoamine transporters-from homology modeling to LeuBAT and dDAT (Q26781554) (← links)
- Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain (Q27333086) (← links)
- Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines (Q28145996) (← links)
- mCPP: an undesired addition to the ecstasy market (Q28238953) (← links)
- Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice (Q28240337) (← links)
- Vesicular neurotransmitter transporters. Potential sites for the regulation of synaptic function (Q28256325) (← links)
- Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone (Q28264655) (← links)
- Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro (Q28272520) (← links)
- The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain (Q28346708) (← links)
- Labelled alpha-methyl-L-tryptophan as a tracer for the study of the brain serotonergic system (Q28361167) (← links)
- In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA (Q28365378) (← links)
- (Q28374341) (← links)
- Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study (Q28483370) (← links)
- Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users (Q28486090) (← links)
- Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient Mice (Q28510046) (← links)
- VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity (Q28512294) (← links)
- 5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study (Q28546929) (← links)
- Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells (Q28553620) (← links)
- Cysteine-scanning mutagenesis of serotonin transporter intracellular loop 2 suggests an alpha-helical conformation (Q28566579) (← links)
- Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use (Q29473848) (← links)
- Raves: a review of the culture, the drugs and the prevention of harm. (Q30327023) (← links)
- Developmental consequences of fetal exposure to drugs: what we know and what we still must learn (Q30395013) (← links)
- Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine (Q30417935) (← links)
- Serotonin: a regulator of neuronal morphology and circuitry (Q30430944) (← links)
- Serotonergic dystrophy induced by excess serotonin (Q30431654) (← links)
- MDMA (Ecstasy) and the Rave: A Review (Q30471049) (← links)
- In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity (Q30535782) (← links)
- Modified structure of the human serotonin transporter promoter (Q30838988) (← links)
- Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice (Q30946517) (← links)
- Statistical prediction of protein chemical interactions based on chemical structure and mass spectrometry data (Q31113004) (← links)
- Prior experience of morphine application alters the c-fos response to MDMA ('ecstasy') and cocaine in the rat striatum (Q31378921) (← links)
- Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity. (Q31454734) (← links)
- The reverse transport of DA, what physiological significance? (Q31804333) (← links)
- Compensatory responses in the aging hippocampal serotonergic system following neurodegenerative injury with 5,7-dihydroxytryptamine (Q31949032) (← links)
- Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats (Q33187198) (← links)
- Membrane trafficking of neurotransmitter transporters in the regulation of synaptic transmission (Q33719397) (← links)
- Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine (Q33799683) (← links)
- Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use. (Q33864810) (← links)
- Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action (Q33869570) (← links)
- Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans (Q33907331) (← links)
- Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study (Q34030711) (← links)